Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.

Rosen CJ, Ingelfinger JR.

N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMe1907458. [Epub ahead of print] No abstract available.

PMID:
31180193
2.

Heterogeneous Nuclear Ribonucleoprotein F Mediates Insulin Inhibition of Bcl2-Modifying Factor Expression and Tubulopathy in Diabetic Kidney.

Ghosh A, Zhao S, Lo CS, Maachi H, Chenier I, Lateef MA, Abdo S, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD.

Sci Rep. 2019 Apr 30;9(1):6687. doi: 10.1038/s41598-019-43218-2.

3.

Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease.

Ingelfinger JR, Rosen CJ.

N Engl J Med. 2019 Jun 13;380(24):2371-2373. doi: 10.1056/NEJMe1904740. Epub 2019 Apr 14. No abstract available.

PMID:
30990261
4.

Tackling Tsc1 to Promote Nephrogenesis.

Ingelfinger JR.

N Engl J Med. 2018 Dec 20;379(25):2476-2478. doi: 10.1056/NEJMcibr1811985. No abstract available.

PMID:
30575479
5.

Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in Adolescents.

Hamdani G, Flynn JT, Becker RC, Daniels SR, Falkner B, Hanevold CD, Ingelfinger JR, Lande MB, Martin LJ, Meyers KE, Mitsnefes M, Rosner B, Samuels JA, Urbina EM.

Hypertension. 2018 Oct;72(4):955-961. doi: 10.1161/HYPERTENSIONAHA.118.11530.

PMID:
30354718
6.

Lorcaserin - Elixir or Liability?

Ingelfinger JR, Rosen CJ.

N Engl J Med. 2018 Sep 20;379(12):1174-1175. doi: 10.1056/NEJMe1810855. Epub 2018 Aug 26. No abstract available.

PMID:
30145932
7.

A Reliable Diagnostic Test for Hypotonic Polyuria.

Rosen CJ, Ingelfinger JR.

N Engl J Med. 2018 Aug 2;379(5):483-484. doi: 10.1056/NEJMe1808195. No abstract available.

PMID:
30067935
8.

A Remembrance of Life before Roe v. Wade.

Ingelfinger JR.

N Engl J Med. 2018 Aug 23;379(8):708-709. doi: 10.1056/NEJMp1809150. Epub 2018 Jul 18. No abstract available.

PMID:
30020848
9.

SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth).

Mendizábal B, Urbina EM, Becker R, Daniels SR, Falkner BE, Hamdani G, Hanevold CD, Hooper SR, Ingelfinger JR, Lande M, Martin LJ, Meyers K, Mitsnefes M, Rosner B, Samuels JA, Flynn JT.

Hypertension. 2018 Sep;72(3):625-631. doi: 10.1161/HYPERTENSIONAHA.118.11434.

PMID:
29987102
10.

A Look Forward - The Frontiers in Medicine Series.

Caulley L, Ramaswami R, Longo DL, Phimister EG, Ingelfinger JR, Ropper AH, Stern K, Burke AE, Knoper KM, Seals JJJ, Müller DC, Drazen JM.

N Engl J Med. 2018 Jul 5;379(1):85-86. doi: 10.1056/NEJMe1806084. No abstract available.

PMID:
29972760
11.

Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.

Zhao XP, Chang SY, Liao MC, Lo CS, Chenier I, Luo H, Chiasson JL, Ingelfinger JR, Chan JSD, Zhang SL.

Sci Rep. 2018 Apr 13;8(1):5958. doi: 10.1038/s41598-018-24220-6.

12.

A Disturbing Legacy of Childhood Kidney Disease.

Ingelfinger JR.

N Engl J Med. 2018 Feb 1;378(5):470-471. doi: 10.1056/NEJMe1716499. No abstract available.

PMID:
29385363
13.

Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.

Zhao S, Ghosh A, Lo CS, Chenier I, Scholey JW, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD.

Endocrinology. 2018 Feb 1;159(2):836-852. doi: 10.1210/en.2017-00752.

14.

Both platelets and fibrin deposition are increased in the glomeruli of mice after treatment with Shiga toxin-2.

Kushak RI, Ozaki M, Rosales IA, Boyle DC, Colvin RB, Ingelfinger JR, Stahl GL, Grabowski EF.

Kidney Int. 2017 Dec;92(6):1556-1557. doi: 10.1016/j.kint.2017.09.009. No abstract available.

PMID:
29153141
15.

Tolvaptan and Autosomal Dominant Polycystic Kidney Disease.

Ingelfinger JR.

N Engl J Med. 2017 Nov 16;377(20):1988-1989. doi: 10.1056/NEJMe1714276. Epub 2017 Nov 4. No abstract available.

PMID:
29105553
16.

Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Aymé S, Bockenhauer D, Day S, Devuyst O, Guay-Woodford LM, Ingelfinger JR, Klein JB, Knoers NVAM, Perrone RD, Roberts J, Schaefer F, Torres VE, Cheung M, Wheeler DC, Winkelmayer WC; Conference Participants.

Kidney Int. 2017 Oct;92(4):796-808. doi: 10.1016/j.kint.2017.06.018. Erratum in: Kidney Int. 2017 Dec;92(6):1558.

17.

A Bacterial IgG-Degrading Enzyme to Unhinge Antibodies.

Ingelfinger JR.

N Engl J Med. 2017 Aug 3;377(5):487-489. doi: 10.1056/NEJMe1707604. No abstract available.

PMID:
28767355
18.

AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression.

Liao MC, Zhao XP, Chang SY, Lo CS, Chenier I, Takano T, Ingelfinger JR, Zhang SL.

J Pathol. 2017 Nov;243(3):279-293. doi: 10.1002/path.4946. Epub 2017 Sep 21.

PMID:
28722118
19.

Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.

Lo CS, Shi Y, Chenier I, Ghosh A, Wu CH, Cailhier JF, Ethier J, Lattouf JB, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD.

Diabetes. 2017 Jul;66(7):1964-1978. doi: 10.2337/db16-1588. Epub 2017 Apr 19.

20.

Increase in the Incidence of Diabetes and Its Implications.

Ingelfinger JR, Jarcho JA.

N Engl J Med. 2017 Apr 13;376(15):1473-1474. doi: 10.1056/NEJMe1616575. No abstract available.

PMID:
28402766
21.

Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.

Ghosh A, Abdo S, Zhao S, Wu CH, Shi Y, Lo CS, Chenier I, Alquier T, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD.

Endocrinology. 2017 Apr 1;158(4):903-919. doi: 10.1210/en.2016-1576.

22.

Averting the legacy of kidney disease: focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F.

Future Sci OA. 2016 Apr 15;2(2):FSO112. doi: 10.4155/fsoa-2016-0001. eCollection 2016 Jun. Review.

23.

Acute Kidney Injury in Critically Ill Children - An Ominous Legacy.

Ingelfinger JR.

N Engl J Med. 2017 Jan 5;376(1):82-83. doi: 10.1056/NEJMe1613456. Epub 2016 Nov 18. No abstract available.

PMID:
27959706
24.

Building Better Bones with Biologics - A New Approach to Osteoporosis?

Rosen CJ, Ingelfinger JR.

N Engl J Med. 2016 Oct 20;375(16):1583-1584. Epub 2016 Sep 18. No abstract available.

PMID:
27641359
25.

Overexpression of angiotensinogen downregulates aquaporin 1 expression via modulation of Nrf2-HO-1 pathway in renal proximal tubular cells of transgenic mice.

Chang SY, Lo CS, Zhao XP, Liao MC, Chenier I, Bouley R, Ingelfinger JR, Chan JS, Zhang SL.

J Renin Angiotensin Aldosterone Syst. 2016 Sep 15;17(3). pii: 1470320316668737. doi: 10.1177/1470320316668737. Print 2016 Jul.

26.

Averting the Legacy of Kidney Disease - Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Kidney Dis (Basel). 2016 Apr;2(1):46-52. doi: 10.1159/000443819. Epub 2016 Feb 11. Erratum in: Kidney Dis (Basel). 2016 Jun;2(2):94.

27.

Averting the Legacy of Kidney Disease-Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; The World Kidney Day Steering Committee.

Children (Basel). 2016 Feb 8;3(1). pii: E4. doi: 10.3390/children3010004. Erratum in: Children (Basel). 2016;3(2). pii: E6. doi: 10.3390/children3020006.

28.

Reply to comment on World Kidney Day 2016: averting the legacy of kidney disease-focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Pediatr Nephrol. 2016 Oct;31(10):1711. doi: 10.1007/s00467-016-3388-3. Epub 2016 Jun 30. No abstract available.

PMID:
27363712
29.

Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope?

Ingelfinger JR, Rosen CJ.

N Engl J Med. 2016 Jul 28;375(4):380-2. doi: 10.1056/NEJMe1607413. Epub 2016 Jun 14. No abstract available.

PMID:
27331286
30.

Erratum to "Averting the legacy of kidney disease-Focus on childhood" [Nephrol. Ther. 12 (1) (2016) 1-5].

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Nephrol Ther. 2016 Jul;12(4):257. doi: 10.1016/j.nephro.2016.05.002. Epub 2016 Jun 14. No abstract available.

PMID:
27316577
31.

Averting the legacy of kidney disease - focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F.

Afr J Prim Health Care Fam Med. 2016 Apr 8;8(1):e1-5. doi: 10.4102/phcfm.v8i1.1093. Review.

32.

[Erratum of "In time: averting the legacy of kidney disease - focus on childhood" [Rev Paul Pediatr. 2016;34(1):5-10]].

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Rev Paul Pediatr. 2016 Jun;34(2):247-248. doi: 10.1016/j.rpped.2016.04.001. Portuguese. No abstract available.

33.

Averting the legacy of kidney disease: focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Nephrol Dial Transplant. 2016 Jun;31(6):1023. doi: 10.1093/ndt/gfw106. Epub 2016 Apr 24. No abstract available.

PMID:
27190326
34.

Erratum to: Averting the legacy of kidney disease: focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

J Nephrol. 2016 Jun;29(3):457. doi: 10.1007/s40620-016-0312-7. No abstract available.

35.

Averting the legacy of kidney disease - focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Braz J Med Biol Res. 2016;49(5):e5314. doi: 10.1590/1414-431X20165314. Epub 2016 Apr 19. Review.

36.

Editorial: World Kidney Day 2016: Averting the Legacy of Kidney Disease--Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Semin Nephrol. 2016 Jan;36(1):1-6. doi: 10.1016/j.semnephrol.2016.01.010.

PMID:
27085729
37.

World Kidney Day 2016: averting the legacy of kidney disease-focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Arch Argent Pediatr. 2016 Apr;114(2):147-53. doi: 10.5546/aap.2016.eng.147. Epub 2016 Feb 19. English, Spanish.

38.

Averting the legacy of kidney disease: focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Curr Opin Organ Transplant. 2016 Jun;21(3):343-8. doi: 10.1097/MOT.0000000000000287. No abstract available.

PMID:
27077601
39.

Averting the legacy of kidney disease: Focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Indian J Nephrol. 2016 Mar-Apr;26(2):71-6. doi: 10.4103/0971-4065.177725. No abstract available.

40.

Averting the legacy of kidney disease-focus on childhood.

Ingelfinger JR, Schaefer F, Kalantar-Zadeh K; World Kidney Day Steering Committee.

J Bras Nefrol. 2016 Mar;38(1):2-8. doi: 10.5935/0101-2800.20160002. English, Portuguese.

41.

Averting the legacy of kidney disease - focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Physiol Int. 2016 Mar;103(1):3-11. doi: 10.1556/036.103.2016.1.1. No abstract available.

PMID:
27030623
42.

Averting the legacy of kidney disease - Focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Saudi J Kidney Dis Transpl. 2016 Mar;27(2):219-26. doi: 10.4103/1319-2442.178201. Review.

43.

World Kidney Day 2016: Averting the legacy of kidney disease. Focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Rev Chil Pediatr. 2016 Mar 10. pii: S0370-4106(16)00015-2. doi: 10.1016/j.rchipe.2016.01.009. [Epub ahead of print] No abstract available.

44.

Averting the Legacy of Kidney Disease--Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Am J Hypertens. 2016 Apr;29(4):537-41. doi: 10.1093/ajh/hpv193. No abstract available. Erratum in: Am J Hypertens. 2016 Jun;29(6):784.

45.

Averting the legacy of kidney disease: focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

J Nephrol. 2016 Apr;29(2):137-142. doi: 10.1007/s40620-016-0270-0. Erratum in: J Nephrol. 2016 Jun;29(3):457.

46.

[World Kidney Day 2016: Averting the legacy of kidney disease. Focus on childhood].

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; en nombre del Comité Directivo del Día Mundial del Riñón.

Rev Chil Pediatr. 2016 Mar-Apr;87(2):82-7. doi: 10.1016/j.rchipe.2016.01.008. Epub 2016 Mar 3. Spanish. No abstract available.

47.

Averting the Legacy of Kidney Disease - Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Blood Purif. 2016;41(4):332-8. doi: 10.1159/000444510. Epub 2016 Mar 1. Erratum in: Blood Purif. 2016;42(1):91.

48.

Averting the Legacy of Kidney Disease - Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Nephron. 2016;132(3):161-7. doi: 10.1159/000444461. Epub 2016 Feb 26. Review. Erratum in: Nephron. 2016;133(1):80.

PMID:
26926120
49.

World Kidney Day 2016: Averting the Legacy of Kidney Disease--Focus on Childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F.

Am J Kidney Dis. 2016 Mar;67(3):349-54. doi: 10.1053/j.ajkd.2015.12.011. No abstract available. Erratum in: Am J Kidney Dis. 2016 Jun;67(6):997.

PMID:
26916370
50.

Averting the legacy of kidney disease: focus on childhood.

Ingelfinger JR, Kalantar-Zadeh K, Schaefer F; World Kidney Day Steering Committee.

Nephrol Dial Transplant. 2016 Mar;31(3):327-31. doi: 10.1093/ndt/gfw003. No abstract available. Erratum in: Nephrol Dial Transplant. 2016 Jun;31(6):1023.

PMID:
26908830

Supplemental Content

Loading ...
Support Center